当前位置: X-MOL 学术Eur. J. Cardiothorac. Surg. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Virtual-assisted lung mapping in sublobar resection of small pulmonary nodules, long-term results
European Journal of Cardio-Thoracic Surgery ( IF 3.1 ) Pub Date : 2021-10-07 , DOI: 10.1093/ejcts/ezab421
Hirokazu Yamaguchi 1 , Masaaki Sato 1 , Kazumichi Yamamoto 1 , Keiko Ueda 2 , Hiroshi Date 3 , Toyofumi Chen-Yoshikawa 3 , Yoshito Yamada 3 , Junko Tokuno 3 , Masahiro Yanagiya 4 , Fumitsugu Kojima 5 , Nobuyuki Yoshiyasu 1, 5 , Masashi Kobayashi 6 , Yasuhiro Nakashima 6 , Terumoto Koike 7 , Jin Sakamoto 8 , Shinji Kosaka 8 , Ryuta Fukai 9 , Tomoki Nishida 9 , Hiroaki Sakai 10 , Shinji Shinohara 11 , Masaru Takenaka 11 , Fumihiro Tanaka 11 , Kenji Misawa 12 , Jun Nakajima 1
Affiliation  

OBJECTIVES The short-term efficacy of virtual-assisted lung mapping (VAL-MAP), a preoperative bronchoscopic multi-spot lung-marking technique, has been confirmed in 2 prospective multicentre studies. The objectives of this study were to analyse the local recurrence and survival of patients enrolled in these studies, long-term. METHODS Of the 663 patients enrolled in the 2 studies, 559 patients’ follow-up data were collected. After excluding those who did not undergo VAL-MAP, whose resection was not for curative intent, who underwent concurrent resection without VAL-MAP, or who eventually underwent lobectomy instead of sublobar resection (i.e. wedge resection or segmentectomy), 422 patients were further analysed. RESULTS Among 264 patients with primary lung cancer, the 5-year local recurrence-free rate was 98.4%, and the 5-year overall survival (OS) rate was 94.5%. Limited to stage IA2 or less (≤2 cm in diameter; n = 238, 90.1%), the 5-year local recurrence-free and OS rates were 98.7% and 94.8%, respectively. Among 102 patients with metastatic lung tumours, the 5-year local recurrence-free rate was 93.8% and the 5-year OS rate was 81.8%. Limited to the most common (colorectal) cancer (n = 53), the 5-year local recurrence-free and OS rates were 94.9% and 82.3%, respectively. CONCLUSIONS VAL-MAP, which is beneficial in localizing small barely palpable pulmonary lesions and determining the appropriate resection lines, was associated with reasonable long-term outcomes. Subj collection 152, 1542

中文翻译:

小肺结节亚肺叶切除的虚拟辅助肺标测,长期结果

目的 虚拟辅助肺标测 (VAL-MAP) 是一种术前支气管镜多点肺标记技术,其短期疗效已在 2 项前瞻性多中心研究中得到证实。本研究的目的是长期分析参加这些研究的患者的局部复发和生存率。方法 2 项研究共纳入 663 例患者,收集 559 例患者的随访资料。在排除未接受 VAL-MAP、切除不是出于治愈目的的患者、未接受 VAL-MAP 的同时切除或最终接受肺叶切除而不是亚肺叶切除(即楔形切除或肺段切除术)的患者后,进一步分析了 422 例患者。 . 结果 264例原发性肺癌患者5年局部无复发率为98.4%,5年总生存率(OS)为94.5%。仅限于 IA2 期或更小(直径≤2 cm;n = 238, 90.1%),5 年局部无复发率和 OS 率分别为 98.7% 和 94.8%。102例转移性肺肿瘤患者5年局部无复发率为93.8%,5年OS率为81.8%。限于最常见的(结直肠)癌症(n = 53),5 年局部无复发率和 OS 率分别为 94.9% 和 82.3%。结论 VAL-MAP 有助于定位几乎无法触及的微小肺部病变并确定适当的切除线,与合理的长期结果相关。主题集合 152, 1542 102例转移性肺肿瘤患者5年局部无复发率为93.8%,5年OS率为81.8%。限于最常见的(结直肠)癌症(n = 53),5 年局部无复发率和 OS 率分别为 94.9% 和 82.3%。结论 VAL-MAP 有助于定位几乎无法触及的微小肺部病变并确定适当的切除线,与合理的长期结果相关。主题集合 152, 1542 102例转移性肺肿瘤患者5年局部无复发率为93.8%,5年OS率为81.8%。限于最常见的(结直肠)癌症(n = 53),5 年局部无复发率和 OS 率分别为 94.9% 和 82.3%。结论 VAL-MAP 有助于定位几乎无法触及的微小肺部病变并确定适当的切除线,与合理的长期结果相关。主题集合 152, 1542 这有利于定位几乎无法触及的小肺部病变并确定适当的切除线,与合理的长期结果相关。主题集合 152, 1542 这有利于定位几乎无法触及的小肺部病变并确定适当的切除线,与合理的长期结果相关。主题集合 152, 1542
更新日期:2021-10-07
down
wechat
bug